ProShare Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$161M Sell
1,859,349
-52,382
-3% -$5.02M 0.24% 84
2025
Q4
$184M Sell
1,911,731
-141,728
-7% -$13.8M 0.32% 68
2025
Q3
$196M Sell
2,053,459
-85,491
-4% -$7.86M 0.41% 54
2025
Q2
$186M Buy
2,138,950
+40,938
+2% +$3.47M 0.37% 63
2025
Q1
$189M Sell
2,098,012
-171,013
-8% -$15.3M 0.43% 65
2024
Q4
$181M Sell
2,269,025
-129,531
-5% -$11.2M 0.41% 77
2024
Q3
$216M Buy
2,398,556
+16,726
+0.7% +$1.41M 0.53% 47
2024
Q2
$187M Buy
2,381,830
+181,183
+8% +$14.9M 0.5% 55
2024
Q1
$192M Sell
2,200,647
-185,421
-8% -$15.8M 0.51% 61
2023
Q4
$197M Buy
2,386,068
+157,129
+7% +$12M 0.6% 41
2023
Q3
$175M Buy
2,228,939
+27,728
+1% +$2.32M 0.54% 51
2023
Q2
$194M Sell
2,201,211
-112,477
-5% -$9.68M 0.56% 39
2023
Q1
$187M Buy
2,313,688
+193,352
+9% +$15.8M 0.57% 35
2022
Q4
$165M Buy
2,120,336
+191,833
+10% +$15.5M 0.58% 69
2022
Q3
$156M Buy
1,928,503
+181,970
+10% +$16.4M 0.6% 42
2022
Q2
$157M Sell
1,746,533
-26,935
-2% -$2.73M 0.52% 58
2022
Q1
$197M Buy
1,773,468
+284,097
+19% +$30M 0.42% 43
2021
Q4
$154M Buy
1,489,371
+162,347
+12% +$18.8M 0.3% 98
2021
Q3
$166M Buy
1,327,024
+94,744
+8% +$12.3M 0.47% 44
2021
Q2
$153M Buy
1,232,280
+73,136
+6% +$9.18M 0.45% 45
2021
Q1
$137M Buy
1,159,144
+54,718
+5% +$6.41M 0.43% 47
2020
Q4
$129M Sell
1,104,426
-35,911
-3% -$3.95M 0.48% 41
2020
Q3
$119M Buy
1,140,337
+129,317
+13% +$13M 0.55% 34
2020
Q2
$92.7M Sell
1,011,020
-36,846
-4% -$3.53M 0.5% 67
2020
Q1
$94.5M Sell
1,047,866
-270,758
-21% -$28.8M 0.68% 33
2019
Q4
$150M Buy
1,318,624
+151,118
+13% +$16.6M 0.69% 24
2019
Q3
$127M Sell
1,167,506
-53,847
-4% -$5.62M 0.71% 22
2019
Q2
$119M Buy
1,221,353
+123,058
+11% +$11.2M 0.71% 20
2019
Q1
$100M Buy
1,098,295
+123,273
+13% +$11M 0.6% 31
2018
Q4
$88.7M Sell
975,022
-4,377
-0.4% -$409K 0.62% 30
2018
Q3
$96.3M Sell
979,399
-46,804
-5% -$4.33M 0.65% 27
2018
Q2
$87.9M Sell
1,026,203
-19,556
-2% -$1.63M 0.59% 31
2018
Q1
$83.9M Sell
1,045,759
-24,405
-2% -$2.01M 0.55% 37
2017
Q4
$86.4M Buy
1,070,164
+208,401
+24% +$16.7M 0.6% 31
2017
Q3
$67M Buy
861,763
+1,585
+0.2% +$132K 0.62% 40
2017
Q2
$76.3M Sell
860,178
-30,800
-3% -$2.6M 0.76% 20
2017
Q1
$71.8M Buy
890,978
+129,504
+17% +$10.1M 0.75% 21
2016
Q4
$54.2M Buy
761,474
+64,886
+9% +$5.1M 0.6% 54
2016
Q3
$60.2M Buy
696,588
+2,715
+0.4% +$237K 0.84% 21
2016
Q2
$60.2M Buy
693,873
+171,518
+33% +$13.9M 0.78% 25
2016
Q1
$39.2M Sell
522,355
-10,701
-2% -$806K 0.54% 32
2015
Q4
$41M Buy
533,056
+75,005
+16% +$5.65M 0.5% 40
2015
Q3
$30.7M Buy
458,051
+30,829
+7% +$2.27M 0.43% 46
2015
Q2
$31.7M Sell
427,222
-20,667
-5% -$1.58M 0.44% 44
2015
Q1
$34.9M Buy
447,889
+108,087
+32% +$8.19M 0.41% 48
2014
Q4
$24.5M Buy
339,802
+95,674
+39% +$6.65M 0.29% 69
2014
Q3
$15.1M Sell
244,128
-9,280
-4% -$590K 0.2% 81
2014
Q2
$16.2M Sell
253,408
-740
-0.3% -$45K 0.21% 83
2014
Q1
$15.6M Buy
254,148
+24,658
+11% +$1.44M 0.2% 83
2013
Q4
$13.2M Buy
229,490
+113,340
+98% +$6.43M 0.2% 88
2013
Q3
$6.18M Sell
116,150
-59,650
-34% -$3.21M 0.15% 109
2013
Q2
$9.05M Buy
+175,800
New +$8.69M 0.18% 99

Other funds holding MDT

ProShare Advisors's MDT Position: Q1 2026 in Review

ProShare Advisors reduced its Medtronic (MDT) stake by 2.7% in Q1 2026, selling an estimated $5.02M and leaving 1,859,349 shares worth $161M. The position accounts for 0.24% of the portfolio, ranked #84.

ProShare Advisors first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $216M in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • ProShare Advisors held 1,859,349 shares of Medtronic worth $161M as of Q1 2026.
  • ProShare Advisors sold 52,382 Medtronic shares in Q1 2026, an estimated $5.02M.
  • Medtronic made up 0.24% of ProShare Advisors's portfolio in Q1 2026, its #84 holding.
  • ProShare Advisors first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • ProShare Advisors's Medtronic position peaked at $216M in Q3 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.